Načítá se...
Breaking barriers to novel analgesic drug development
Acute and chronic pain complaints, while very common, are generally poorly served by existing therapies. The unmet clinical need reflects the failure in developing novel classes of analgesics with superior efficacy, diminished adverse effects and a lower abuse liability than those currently availabl...
Uloženo v:
| Vydáno v: | Nat Rev Drug Discov |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5675565/ https://ncbi.nlm.nih.gov/pubmed/28596533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrd.2017.87 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|